• Adenosine Triphosphate (ATP): Applied Workflows in Metabolic

  2026-06-26

  Harness the full spectrum of Adenosine Triphosphate (ATP) for metabolic pathway interrogation and purinergic receptor signaling assays. Discover evidence-driven protocols, troubleshooting strategies, and the latest insights bridging enzyme regulation and cellular energetics—empowering reproducible, high-impact research.

• Canagliflozin: SGLT2 Inhibitor Workflows for Renal Research

  2026-06-26

  Canagliflozin enables researchers to dissect renal glucose handling and mitochondrial remodeling in diabetic models, going far beyond glycemic endpoints. Here, we detail optimized protocols, troubleshooting tips, and the latest insights on mitochondrial mechanisms, equipping metabolic disease labs with actionable guidance.

• Ionic Regulation of Cancer Cell Stiffness via MRTFA-KCNMB1 A

  2026-06-25

  Gajda et al. uncover a novel regulatory pathway in which the MRTFA-KCNMB1 axis modulates cancer cell stiffness, influencing metastatic potential and immune evasion. Their findings highlight potassium channel activity as a therapeutic target for reducing metastasis by altering biophysical properties of tumor cells.

• Network Pharmacology of CEP in Nasopharyngeal Carcinoma: Ins

  2026-06-25

  This study leverages network pharmacology, molecular docking, and in vivo experiments to elucidate how Cepharanthine (CEP) inhibits nasopharyngeal carcinoma (NPC) via the EGFR/PI3K/AKT/mTOR pathway. The findings highlight novel multi-targeted mechanisms and provide a data-rich foundation for future cancer research and therapeutic strategies.

• Targeted mRNA Nanoparticles Repair the BBB After Stroke via

  2026-06-24

  This study introduces a lipid nanoparticle system for targeted delivery of mRNA encoding interleukin-10 to ischemic brain regions, effectively promoting microglia polarization toward a protective phenotype. The approach demonstrates significant restoration of the blood–brain barrier and resolution of neuroinflammation post-stroke, offering a translational advance for mRNA therapeutics in neuroprotection.

• Z-DEVD-FMK: Caspase-3 Inhibitor for Apoptosis and Neuroprote

  2026-06-23

  Z-DEVD-FMK stands apart as a dual-action caspase-3 inhibitor and calpain suppressor, empowering researchers to dissect apoptosis and neuroprotective mechanisms with precision. Its workflow flexibility and proven performance in both cell-based and in vivo models make it a preferred tool for advanced cell death studies.

• GABA-Independent Mechanoactivation of GABAB Receptors by Int

  2026-06-23

  This study reveals that GABAB receptors can be activated by mechanical forces, independent of their classical ligand, GABA. The findings uncover a direct role for integrin-mediated mechanical signaling in GABAB receptor activation, expanding our understanding of GPCR mechano-transduction and its relevance to astrocyte remodeling.

• EZ Cap™ Cy5 EGFP mRNA (5-moUTP): Dual-Reporter Assay Advance

  2026-06-22

  EZ Cap™ Cy5 EGFP mRNA (5-moUTP) enables real-time, dual-fluorescence tracking of mRNA delivery and translation in live cells. Its Cap 1 structure and 5-methoxyuridine modifications set a new standard for immune-evasive, quantitative gene delivery assays. Discover how this APExBIO innovation optimizes experimental workflows and troubleshooting for next-generation mRNA research.

• Amplifying Osteogenesis Research: Cy5 Antibodies for Transla

  2026-06-22

  This thought-leadership article explores how integrating high-sensitivity Cy5 Goat Anti-Mouse IgG (H+L) Antibody solutions into advanced fluorescent immunoassays can accelerate translational bone regeneration research. By bridging mechanistic insights—such as lithium-stimulated exosomal Wnt10a signaling in osteogenesis—with strategic workflow innovation, it guides researchers in designing robust, reproducible studies and overcoming detection bottlenecks in immunohistochemistry, immunocytochemistry, and beyond.

• Bismuth Subsalicylate in Apoptosis Models: Beyond GI Researc

  2026-06-21

  Explore how Bismuth Subsalicylate empowers advanced apoptosis and membrane integrity assays, extending its value beyond conventional gastrointestinal disorder research. Discover scientific insights and protocol optimization grounded in current literature.

• Rotigotine Hydrochloride: Dopamine D2/D3 Agonist in PD Resea

  2026-06-20

  Rotigotine hydrochloride enables precise modulation of dopaminergic pathways with robust neuroprotection in both motor and non-motor Parkinson’s disease models. This guide details advanced experimental workflows, troubleshooting strategies, and novel insights from recent studies, positioning Rotigotine as an indispensable tool for dopaminergic signaling research.

• IPA-3 in Translational Research: Dissecting Pak1 Pathways an

  2026-06-19

  Explore the unique mechanism of IPA-3, a selective Pak1 inhibitor, and its strategic applications in kinase activity assays and neuroinflammation research. Gain deeper insight into how IPA-3 advances experimental design and interpretation beyond conventional approaches.

• Clarithromycin: CYP3A Inhibitor Workflows for Drug Interacti

  2026-06-19

  Clarithromycin's robust CYP3A inhibition empowers translational researchers to model, quantify, and troubleshoot complex drug-drug interactions, especially in cardiovascular and statin metabolism studies. This workflow-focused guide delivers practical steps, protocol parameters, and advanced troubleshooting, leveraging APExBIO’s high-purity reagent and the latest comparative insights.

• HATU in Peptide Synthesis: Precision Coupling for Advanced I

  2026-06-18

  HATU streamlines amide bond formation with unmatched efficiency, empowering the rapid synthesis of complex peptide-based inhibitors. Discover how this reagent accelerates experimental workflows, minimizes troubleshooting, and directly supports high-selectivity drug discovery campaigns.

• (S)-(+)-Dimethindene maleate for M2 Muscarinic Antagonism Wo

  2026-06-18

  (S)-(+)-Dimethindene maleate enables selective antagonism of muscarinic M2 and histamine H1 receptors, supporting precise investigations in autonomic regulation and cardiovascular or respiratory physiology. The compound is not intended for diagnostic or therapeutic use, and care must be taken to adhere to its solubility and stability specifications for reliable research outcomes.

15349 records 1/1024 page Next 12345 下5页 Last page